【China Chemical】Announcement of the Board's Approval of the Q1 2026 Individual Financial Report
Key facts
- 【China Chemical】Announcement of the Board's Approval of the Q1 2026 Individual Financial Report
- China Chemical & Pharmaceutical has announced that its Board of Directors approved the individual financial report for Q1 2026. The report states operating revenue of NT$519.337 million, net profit attributable to parent company owners of NT$35.899 million, and basic EPS of NT$0.28.
- Source: PR Times
- Date: May 13, 2026
Direct answer
China Chemical & Pharmaceutical has announced that its Board of Directors approved the individual financial report for Q1 2026. The report states operating revenue of NT$519.337 million, net profit attributable to parent company owners of NT$35.899 million, and basic EPS of NT$0.28.
- Citation
- 【China Chemical】Announcement of the Board's Approval of the Q1 2026 Individual Financial Report (May 13, 2026), PR Times
- Source
- PR Times
- Date
- May 13, 2026
China Chemical & Pharmaceutical has announced that its Board of Directors approved the individual financial report for Q1 2026. The report states operating revenue of NT$519.337 million, net profit attributable to parent company owners of NT$35.899 million, and basic EPS of NT$0.28.
📋 Article Processing Timeline
- 📰 Published: May 13, 2026 at 09:00
- 🔍 Collected: May 14, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 14, 2026 at 09:21 (1h 21m after Collected)
2. Date of approval by the Audit Committee: 2026/05/12
3. Reporting period for financial reports or annual self-declared financial information
Start and end dates (XXX/XX/XX~XXX/XX/XX): 2026/01/01~2026/03/31
4. Cumulative operating revenue from January 1 to the end of this period (in thousands of NTD): 519,337
5. Cumulative operating gross profit (loss) from January 1 to the end of this period (in thousands of NTD): 93,230
6. Cumulative operating profit (loss) from January 1 to the end of this period (in thousands of NTD): 43,151
7. Cumulative net profit (loss) before tax from January 1 to the end of this period (in thousands of NTD): 41,099
8. Cumulative net profit (loss) for this period from January 1 to the end of this period (in thousands of NTD): 35,899
9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands of NTD): 35,899
10. Basic earnings per share (loss) from January 1 to the end of this period (in NTD): 0.28
11. Total assets at the end of the period (in thousands of NTD): 3,624,612
12. Total liabilities at the end of the period (in thousands of NTD): 1,513,893
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 2,110,719
14. Other matters that should be specified: None
Keywords: Material Information
FAQ
What are the key facts in this article?
China Chemical & Pharmaceutical has announced that its Board of Directors approved the individual financial report for Q1 2026. The report states operating revenue of NT$519.337 million, net profit attributable to parent company owners of NT$35.899 million, and basic EPS of NT$0.28.
What is the direct answer?
China Chemical & Pharmaceutical has announced that its Board of Directors approved the individual financial report for Q1 2026. The report states operating revenue of NT$519.337 million, net profit attributable to parent company owners of NT$35.899 million, and basic EPS of NT$0.28.
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-1727-2026-05-13-fc6afc72 | May 13, 2026